EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study—Report 9

Patrícia Barreto, Cláudia Farinha, Rita Coimbra, Maria Luz Cachulo, Joana Barbosa Melo, Yara Lechanteur, Carel B Hoyng, José Cunha-Vaz, Rufino Silva

Investigative Ophthalmology & Visual Science · 2024-06-27 · 65 (6) · 38

DOI: 10.1167/iovs.65.6.38 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, published on 2024-06-27. Written by Patrícia Barreto and 8 co-authors. Institution: Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal. Major MEDLINE topics: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Disease Progression, Macular Degeneration. Cited 11 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

To assess the association of age-related macular degeneration (AMD) progression and statins, connected with AMD genetic risk, and if there is an interplay between statins and genetics.

Methods

In this analysis, 682 subjects made two visits (6.5-year follow-up) of the Coimbra Eye Study. Subjects who started taking statins at any time point between the two visits were considered. Progressors were defined as not having AMD at baseline and having any AMD at follow-up. Genetic risk scores (GRSs) were calculated individually with 52 independent variants associated with AMD. Time to progression was estimated using unadjusted Kaplan-Meier curves. An extended Cox model was used for the association between statins and GRS with the risk for AMD progression. Multiplicative and additive interactions were assessed.

Results

Median survival time was 7.50 years for subjects not taking statins and 7.62 for subjects taking statins (P < 0.001). Statin intake reduced the risk for progression to AMD in 48%, adjusting for age, sex, body mass index, smoking, and diabetes (model 1) and GRS (model 2). The combined effects of not taking statins and having high GRS increased the progression risk fourfold compared to taking statins and having low GRS (hazard ratio [HR] = 4.25; 95% confidence interval [CI], 1.62-11.16; P = 0.003). For subjects not taking statins, an increased risk of progression was found for those subjects with high GRS compared to subjects with low GRS (HR = 1.80; 95% CI, 1.13-2.85; P = 0.013). No statistically significant multiplicative or additive interactions were found.

Conclusions

Statins seem to be protective against AMD progression, and genetics may play a role in treatment response.

Subjects

MeSH terms (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsDisease ProgressionMacular DegenerationHumansMaleFemaleAgedFollow-Up StudiesRisk FactorsMiddle AgedAged, 80 and overPolymorphism, Single NucleotideGenetic Predisposition to Disease

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Authors and institutions

  • Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal.
  • Faculty of Medicine, Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, Coimbra, Portugal.
  • Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.
  • Ophthalmology Department, Coimbra Hospital and University Center (CHUC), Coimbra, Portugal.
  • Faculty of Medicine, Clinical Academic Center of Coimbra (CACC), University of Coimbra, Portugal.
  • Department of Mathematics, University of Aveiro, Aveiro, Portugal.

Cite

APA

Barreto, P., Farinha, C., Coimbra, R., Cachulo, M. L., Melo, J. B., Lechanteur, Y., Hoyng, C. B., Cunha-Vaz, J., & Silva, R. (2024). Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study—Report 9. Investigative Ophthalmology & Visual Science, 65(6), 38. https://doi.org/10.1167/iovs.65.6.38

Vancouver

Barreto P, Farinha C, Coimbra R, Cachulo ML, Melo JB, Lechanteur Y, et al. Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study—Report 9. Investigative Ophthalmology & Visual Science. 2024;65(6):38. doi:10.1167/iovs.65.6.38

BibTeX
@article{Barreto2024,
  author = {Barreto, Patrícia and Farinha, Cláudia and Coimbra, Rita and Cachulo, Maria Luz and Melo, Joana Barbosa and Lechanteur, Yara and Hoyng, Carel B and Cunha-Vaz, José and Silva, Rufino},
  title = {Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study—Report 9},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2024},
  volume = {65},
  number = {6},
  pages = {38},
  doi = {10.1167/iovs.65.6.38}
}
Start for free →